Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by longonMJon Mar 17, 2018 1:31pm
152 Views
Post# 27733733

RE:CMED Earnings Monday Morning, how will affect ACB?

RE:CMED Earnings Monday Morning, how will affect ACB?Well, hopefully a lot better than last time when we saw significant downward pressure on the share price to the tune of -35%, even though the company reported much improved financials in the form of a 70% increase in sales revenue along with a 40% drop in their net loss figure.

Of course, that also coincided with the early stages of the weed sector market crash which was an obvious facor in the continuing falling share price.  So, I hope the less toxic trading environment which we currently have will have a positive influence on the share price for this go round here.

MGK1977 wrote: NOW that we have over 86% of Cmed shares how will good earnings affect ACB....


Bullboard Posts